Identification of instability elements in the 3′-untranslated region of the human thrombin-activatable fibrinolysis inhibitor mRNA

被引：0
|
作者：
Kuo, A [1 ]
Boffa, M [1 ]
Koschinsky, M [1 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [31] Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia
    Malyszko, J
    Malyszko, JS
    Hryszko, T
    Mysliwiec, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2219 - 2221
  • [32] Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism
    Yildiz, Abdulkerim
    Katar, Didem
    Soydas, Ayse Ozden
    Albayrak, Murat
    HAMOSTASEOLOGIE, 2022, 42 (03): : 180 - 184
  • [33] Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) phenotype in severe sepsis
    Francisco, E
    Ruiz-Rodríguez, JC
    Caballero, J
    Monasterio, J
    Bóveda, JL
    INTENSIVE CARE MEDICINE, 2002, 28 : S17 - S17
  • [34] Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss
    Masini, Silvia
    Ticconi, Carlo
    Gravina, Paolo
    Tomassini, Monica
    Pietropolli, Adalgisa
    Forte, Vittorio
    Federici, Giorgio
    Piccione, Emilio
    Bernardini, Sergio
    FERTILITY AND STERILITY, 2009, 92 (02) : 694 - 702
  • [35] Role of Thrombin-Activatable Fibrinolysis Inhibitor in Allergic Bronchial Asthma
    Atsushi Fujiwara
    Osamu Taguchi
    Takehiro Takagi
    Corina N. D’Alessandro-Gabazza
    Daniel Boveda-Ruiz
    Masaaki Toda
    Atsushi Yasukawa
    Yuki Matsushima
    Yasushi Miyake
    Hiroyasu Kobayashi
    Tetsu Kobayashi
    Paloma Gil-Bernabe
    Masahiro Naito
    Masamichi Yoshida
    John Morser
    Yoshiyuki Takei
    Esteban C. Gabazza
    Lung, 2012, 190 : 189 - 198
  • [36] Structure-function relationships in thrombin-activatable fibrinolysis inhibitor
    Plug, T.
    Meijers, J. C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) : 633 - 644
  • [37] Thrombin-activatable fibrinolysis inhibitor activity in healthy and diseased dogs
    Jessen, Lisbeth R.
    Wiinberg, Bo
    Kjelgaard-Hansen, Mads
    Jensen, Asger L.
    Rozanski, Elizabeth
    Kristensen, Annemarie T.
    VETERINARY CLINICAL PATHOLOGY, 2010, 39 (03) : 296 - 301
  • [38] Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis
    Lisman, T
    Leebeek, FWG
    Mosnier, LO
    Bouma, BN
    Meijers, JCM
    Janssen, HLA
    Nieuwenhuis, HK
    De Groot, PG
    GASTROENTEROLOGY, 2001, 121 (01) : 131 - 139
  • [39] Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets
    Mosnier, LO
    Buijtenhuijs, P
    Marx, PF
    Meijers, JCM
    Bouma, BN
    BLOOD, 2003, 101 (12) : 4844 - 4846
  • [40] Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometry
    Wheeler, Jun X.
    Thelwell, Craig
    Rigsby, Peter
    Whiting, Gail
    ANALYTICAL BIOCHEMISTRY, 2022, 638
12345